In this week’s Video Forum, Lokesh Ohri, Americas consumer consulting leader and a principal at EY, analyzes the changing behavior of shoppers in the wake of the COVID pandemic. Ohri also shares insights about building and maintaining customer loyalty, and the significance of artificial intelligence and other cutting-edge technology on the consumer marketplace.
Video Forum: Lokesh Ohri, EY, Part 1
In this week’s Video Forum, Lokesh Ohri, Americas consumer consulting leader and a principal at EY, analyzes the changing behavior of shoppers in the wake of the COVID pandemic.
Related
Kroger-Albertsons merger goes on trial in an Oregon federal court
The FTC faces off against lawyers from Albertsons and Kroger in a fight over competition in the grocery channel.
FDA approves Moderna’s updated COVID-19 vaccine
Moderna's updated COVID-19 vaccine targets the KP.2 variant of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older.
Kroger sues FTC, claims merger challenge violates Constitution
The company argues that by proceeding in its administrative tribunal, in addition to the separate action in federal court, the FTC is violating Constitutional protections.
CRN to Federal Appeals Court: NY AG’s arguments don’t support denial of preliminary injunction in NY age restrictions case
CRN’s most recent brief argues that the NY AG does not meaningfully address CRN’s arguments about the Act’s constitutional infirmities.
Latest
Sanofi and USA Pickleball launch COVID-19 education campaign
Despite their risk of serious illness from COVID-19, nearly 70% of adults 65 and older remain unvaccinated, in part due to concerns about potential side effects
AAM: Generics and biosimilars saved U.S. health system $496 billion in 2025
Generics and biosimilars represented 89% of U.S. prescriptions but only 12% of prescription drug spending in 2025, according to AAM.
FMI issues statement on August 2026 CPI Food Price numbers
“The August CPI numbers bring some modest relief for grocery shoppers,” FMI said.
Study links mRNA flu vaccine to sustained immune response
Researchers found an mRNA flu vaccine produces broader antibodies than conventional ones, offering clues for more lasting influenza protection.